TCG Crossover Management, LLC Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$566.6B
Holdings
21
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OPHTEURIVERIC BIO INC | 5,141,118 | $110K | 0.00% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS INC | 288,054 | $83K | 0.00% | |
| 3 | COGTCOGENT BIOSCIENCES INC | 3,631,042 | $41K | 0.00% | |
| 4 | CBAYUSDCYMABAY THERAPEUTICS INC | 5,905,400 | $37K | 0.00% | |
| 5 | GONGERON CORP | 15,187,073 | $36K | 0.00% | |
| 6 | SLNSILENCE THERAPEUTICS PLC | 2,104,875 | $32K | 0.00% | |
| 7 | AVTEAEROVATE THERAPEUTICS INC | 1,081,274 | $31K | 0.00% | |
| 8 | VRDNVIRIDIAN THERAPEUTICS, INC | 983,610 | $28K | 0.00% | |
| 9 | VTYXVENTYX BIOSCIENCES, INC | 787,231 | $25K | 0.00% | |
| 10 | KALVKALVISTA PHARMACEUTICALS, INC | 3,395,495 | $22K | 0.00% | |
| 11 | —VECTIVBIO HOLDING AG | 2,333,300 | $20K | 0.00% | |
| 12 | ACRSACLARIS THERAPEUTICS INC | 1,144,939 | $18K | 0.00% | |
| 13 | KURAKURA ONCOLOGY INC | 1,423,642 | $17K | 0.00% | |
| 14 | IMVTIMMUNOVANT, INC | 854,853 | $15K | 0.00% | |
| 15 | TYRATYRA BIOSCIENCES INC | 1,989,103 | $15K | 0.00% | |
| 16 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 1,000,000 | $10K | 0.00% | |
| 17 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $7K | 0.00% | |
| 18 | CABACABALETTA BIO, INC | 486,795 | $4K | 0.00% | |
| 19 | MRUSMERUS BV | 300,000 | $4K | 0.00% | |
| 20 | NVLSEURALPINE IMMUNE SCIENCES INC | 253,069 | $1K | 0.00% | |
| 21 | —ELEVATION ONCOLOGY INC | 288,390 | $0 | 0.00% |